Skip to main content
. 2018 Jun 20;11(1):e1531. doi: 10.1002/wnan.1531

Figure 4.

Figure 4

Relevance of the physicochemical parameters for the regulatory decision‐making evaluated in surveys performed within regulatory communities: International Pharmaceutical Regulators Forum (IPRF, first survey), EU‐innovation network (second survey), and “Bridging communities in the field of nanomedicine” workshop of the Joint Research Centre of the European Commission (JRC, third survey)